Intrinsic Value

The intrinsic value of Metro Healthcare Indonesia Tbk PT (CARE) under the Base Case is 45.13 IDR per share. Compared with the current market price of 356 IDR, the stock appears Overvalued by 87% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

CARE Intrinsic Value
Rp45.13
Overvaluation 87%
Intrinsic Value
Price Rp356
Alert me when CARE is below its intrinsic value
Today Rp36.11 · 89.9% below the current price

CARE is cheaper than usual. Still overvalued, but less so than on 80% of days in the past 5 years.

Alternatives to CARE

Fundamental Analysis

What Metro Healthcare Indonesia Tbk PT Does

Health Care

Metro Healthcare Indonesia is a healthcare provider in Indonesia that runs hospitals and related medical facilities. It treats patients through outpatient visits, inpatient care, emergency services, diagnostic tests, and other hospital services. It does not make medicines; it makes money by charging patients, insurers, and other payers for the care delivered inside its facilities.

Headquarters
Indonesia ID
Employees
881
IPO date
Mar 13, 2020
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Metro Healthcare Indonesia Tbk PT

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one CARE stock?

The intrinsic value for Metro Healthcare Indonesia Tbk PT (CARE) under the Base Case is 45.13 IDR.

Is CARE stock undervalued or overvalued?

Compared with the current market price of 356 IDR, the stock appears Overvalued by 87% .

Back to Top